Skip to main content

Nonprofit · EIN 23-7376197

HUNTINGTON S DISEASE FOUNDATION

Tax-exempt · NEW YORK, NY 10032

Financials

$3.8M$3M2021$2.6M$4.7M2023$7.9M$4.5M2024$4.1M$4.3M2025
Revenue Expenses · by fiscal year end
Financials of HUNTINGTON S DISEASE FOUNDATION by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2025990$4,081,669$4,326,391-$244,722$23,135,759$2,314,242$20,821,517
December 31, 2024990$7,899,221$4,524,145$3,375,076$21,978,294$2,828,419$19,149,875
December 31, 2023990$2,578,841$4,738,635-$2,159,794$18,234,308$3,091,412$15,142,896
December 31, 2021990$3,846,649$2,967,624$879,025$18,145,612$2,330,017$15,815,595
Financial details: 990 for the year ended December 31, 2025

Revenue

Contributions, gifts and grants
$3,254,595
Program service revenue
$52,500
Investment income
$634,776
Net gain from sales of assets
$138,594
Other revenue
$139,798

Expenses

Grants and similar amounts paid
$3,152,522
Compensation of officers, directors and key employees
$370,448
Other salaries and wages
$184,852
Salaries, compensation and benefits (total)
$618,915
Professional fundraising fees
$0
Accounting fees
$38,000
Occupancy
$41,152
Program services (functional)
$3,796,690
Management and general (functional)
$284,027
Fundraising (functional)
$245,674

Balance sheet and other

Total assets, start of year
$21,978,294
Total assets, end of year
$23,135,759
Total liabilities, end of year
$2,314,242
Net assets, end of year
$20,821,517
Publicly traded securities
$20,950,224
Net assets without donor restrictions
$4,315,422
Net assets with donor restrictions
$16,506,095
Gross receipts
$11,041,255
Employees
4
Volunteers
45
Year formed
1968
State of legal domicile
CA

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2025, highest compensation first.

NameTitleHours / weekCompensationOther / benefits
SARAH HERNANDEZ PHDDIR. OF RESEARCH PROGRAMS
Highest-paid employee
40$155,000$61,927
JULIE PORTERDIR. OF ADMINISTRATION
Highest-paid employee
40$124,000$33,541
KAREN NEWMANCHAIR
Trustee or director, Officer
24$72,000$0
MEGHAN DONALDSONCEO
Trustee or director, Officer
40$50,000$0
TIM KELLEHERCFO
Officer
6$31,521$0
NANCY S WEXLER PHDPRESIDENT
Trustee or director, Officer
1$0$0
ANNE B YOUNG MD PHDVICE CHAIR
Trustee or director, Officer
1$0$0
BRUCE DONALDSONTREASURER
Trustee or director, Officer
1$0$0
ALICE WEXLER PHDSECRETARY
Trustee or director, Officer
1$0$0
C FRANK BENNETT PHDDIRECTOR
Trustee or director
1$0$0
ROBI BLUMENSTEINDIRECTOR
Trustee or director
1$0$0
SANDY FOXDIRECTOR
Trustee or director
1$0$0
TACIE FOXDIRECTOR
Trustee or director
1$0$0
BERTA A GEHRYDIRECTOR
Trustee or director
1$0$0
FRANK O GEHRYDIRECTOR (THROUGH 12/5/25)
Trustee or director
1$0$0
6 more people on this return
NameTitleHours / weekCompensation
DAVID HOUSMAN PHDDIRECTOR
Trustee or director
1$0
THOMAS OBERSTEINERDIRECTOR (JOINED 4/25)
Trustee or director
1$0
LAUREN BAKER PINKUSDIRECTOR
Trustee or director
1$0
LESLIE M THOMPSON PHDDIRECTOR
Trustee or director
1$0
DAVID ZWALLYDIRECTOR
Trustee or director
1$0
MELISSA MOSERDIRECTOR
Trustee or director
1$0
990 for the year ended December 31, 2024: 23 people
NameTitleHours / weekCompensationOther / benefits
SARAH HERNANDEZDIR. OF RESEARCH PROGRAMS
Highest-paid employee
40$143,929$55,917
JULIE PORTERDIR. OF ADMINISTRATION
Highest-paid employee
40$116,065$30,005
MEGHAN DONALDSONCEO
Trustee or director, Officer
40$110,000$0
ERICA MATISZDIR. OF DEVELOPMENT
Highest-paid employee
40$108,500$0
TIM KELLEHERCFO
Officer
6$42,765$0
KAREN NEWMANCHAIR
Trustee or director, Officer
24$12,000$0
NANCY S WEXLER PHDPRESIDENT
Trustee or director, Officer
1$0$0
ANNE B YOUNG MD PHDVICE CHAIR
Trustee or director, Officer
1$0$0
BRUCE DONALDSONTREASURER
Trustee or director, Officer
1$0$0
ALICE WEXLER PHDSECRETARY
Trustee or director, Officer
1$0$0
C FRANK BENNETT PHDDIRECTOR
Trustee or director
1$0$0
ROBI BLUMENSTEINDIRECTOR
Trustee or director
1$0$0
SANDY FOXDIRECTOR
Trustee or director
1$0$0
TACIE FOXDIRECTOR
Trustee or director
1$0$0
BERTA A GEHRYDIRECTOR
Trustee or director
1$0$0
FRANK O GEHRYDIRECTOR
Trustee or director
1$0$0
DAVID HOUSMAN PHDDIRECTOR
Trustee or director
1$0$0
JOAN LEIMAN PHDDIRECTOR
Trustee or director
1$0$0
HERBERT PARDES MDDIRECTOR (THROUGH 4/24)
Trustee or director
1$0$0
LAUREN BAKER PINKUSDIRECTOR
Trustee or director
1$0$0
LESLIE M THOMPSON PHDDIRECTOR
Trustee or director
1$0$0
DAVID ZWALLYDIRECTOR
Trustee or director
1$0$0
MELISSA MOSERDIRECTOR
Trustee or director
1$0$0
990 for the year ended December 31, 2023: 22 people
NameTitleHours / weekCompensationOther / benefits
SARAH HERNANDEZDIR. OF RESEARCH PROGRAMS
Highest-paid employee
40$125,220$41,237
JULIE PORTERDIR OF ADMINISTRATION
Highest-paid employee
40$112,648$16,953
MEGHAN DONALDSONCEO
Trustee or director, Officer
40$110,000$0
TRAVIS CAREYCFO
Officer
6$43,995$0
ALICE WEXLER PHDSECRETARY
Trustee or director, Officer
1$0$0
KAREN NEWMANCHAIR
Trustee or director, Officer
15$0$0
NANCY S WEXLER PHDPRESIDENT
Trustee or director, Officer
1$0$0
ANNE B YOUNG MD PHDVICE CHAIR
Trustee or director, Officer
1$0$0
BRUCE DONALDSONTREASURER
Trustee or director, Officer
1$0$0
C FRANK BENNETT PHDDIRECTOR
Trustee or director
1$0$0
ROBI BLUMENSTEINDIRECTOR
Trustee or director
1$0$0
BARRY EVENCHICKDIRECTOR THRU 9/23
Trustee or director
1$0$0
SANDY FOXDIRECTOR
Trustee or director
1$0$0
TACIE FOXDIRECTOR
Trustee or director
1$0$0
BERTA A GEHRYDIRECTOR
Trustee or director
1$0$0
FRANK O GEHRYDIRECTOR
Trustee or director
1$0$0
DAVID HOUSMAN PHDDIRECTOR
Trustee or director
1$0$0
JOAN LEIMAN PHDDIRECTOR
Trustee or director
1$0$0
HERBERT PARDES MDDIRECTOR
Trustee or director
1$0$0
LAUREN BAKER PINKUSDIRECTOR
Trustee or director
1$0$0
LESLIE M THOMPSON PHDDIRECTOR
Trustee or director
1$0$0
DAVID ZWALLYDIRECTOR
Trustee or director
1$0$0
990 for the year ended December 31, 2021: 17 people
NameTitleHours / weekCompensation
MEGHAN DONALDSONCEO
Trustee or director, Officer
40$110,000
TRAVIS CAREYCFO
Officer
3$7,700
NANCY S WEXLER PHDPRESIDENT
Trustee or director, Officer
7$0
DAVID ZWALLYCHAIR
Trustee or director, Officer
1$0
ANNE B YOUNG MD PHDVICE CHAIR
Trustee or director, Officer
1$0
BRUCE DONALDSONTREASURER
Trustee or director, Officer
1$0
ALICE WEXLER PHDSECRETARY
Trustee or director, Officer
1$0
ROBI BLUMENSTEINDIRECTOR
Trustee or director
1$0
BARRY EVENCHICKDIRECTOR
Trustee or director
1$0
SANDY FOXDIRECTOR
Trustee or director
1$0
BERTA A GEHRYDIRECTOR
Trustee or director
1$0
FRANK O GEHRYDIRECTOR
Trustee or director
1$0
KELLY POSNER GERSTENHABER PHDDIRECTOR
Trustee or director
1$0
DAVID HOUSMAN PHDDIRECTOR
Trustee or director
1$0
JOAN LEIMAN PHDDIRECTOR
Trustee or director
1$0
KAREN NEWMANDIRECTOR
Trustee or director
1$0
HERBERT PARDES MDDIRECTOR
Trustee or director
1$0

Address and contacts

Address (IRS master file)
ATTN MEGHAN DONALDSON, NEW YORK, NY 10032-0000
In care of
% MEGHAN DONALDSON
Principal officer (990 for 2025)
MEGHAN DONALDSON, 601 WEST 168TH STREET 54, NEW YORK, NY 10032
Signed the 990
MEGHAN DONALDSON, CEO
Phone
(212) 928-2121
Return prepared by
SAX ADVISORS LLC

Mission

TO FUND TRANSFORMATIVE RESEARCH TO FIND TREATMENTS, AND ULTIMATELY A CURE, FOR HUNTINGTON'S DISEASE.

990 for the year ended December 31, 2025

Program accomplishments

  • HUNTINGTON'S DISEASE FOUNDATION (HDF) ADVANCES PARADIGM-CHANGING HUNTINGTON'S DISEASE (HD) RESEARCH THROUGH A COLLABORATIVE APPROACH TO SCIENTIFIC DISCOVERY. WE INVEST IN RESEARCH BY PROVIDING SENIOR SCIENTISTS WITH GRANTS, INCLUDING OUR MILLION-DOLLAR TRANSFORMATIVE RESEARCH AWARDS, WHICH BEGAN IN 2023, AND FUNDING THE WORK OF EARLY CAREER SCIENTISTS THROUGH POSTDOCTORAL FELLOWSHIPS. WE CHAMPION COLLABORATIVE SCIENCE BY ORGANIZING BOTH SMALL THINKTANK-STYLE WORKSHOPS AND LARGE SCIENTIFIC CONFERENCES WHICH ENABLE EXPERTS IN HD TO SHARE THEIR LATEST DISCOVERIES, EXPLORE CUTTING-EDGE TECHNOLOGIES, AND FORM COLLABORATIONS. WE HIGHLIGHT FOR THE PUBLIC NOTABLE WORK OF SCIENTISTS THROUGH OUR WEBINARS.(CONTINUED ON SCHEDULE O)IN ITS EARLY YEARS, RESEARCH ORGANIZED AND FUNDED BY THE HDF WAS THE CATALYST FOR THE WORK THAT ISOLATED THE GENE THAT CAUSES HUNTINGTON'S DISEASE. THIS FINDING LED TO THE DEVELOPMENT OF A GENETIC TEST FOR HD AND LAUNCHED MODERN RESEARCH EFFORTS. THE HUNTINGTON'S DISEASE FOUNDATION SUPPORTS RESEARCH THROUGH SEVERAL FUNDING OPPORTUNITIES.HDF RESEARCH GRANTS: ONE-YEAR GRANTS PROVIDE SENIOR RESEARCHERS WITH SEED FUNDING TO ENABLE THEM TO COLLECT THE PRELIMINARY DATA NEEDED TO OBTAIN MAJOR, LONG-TERM FUNDING FROM OTHER ORGANIZATIONS, INCLUDING THE NIH.HDF POSTDOCTORAL FELLOWSHIPS: TWO-YEAR FELLOWSHIPS FUND THE WORK OF EARLY-CAREER SCIENTISTS. THESE FELLOWSHIPS ARE INTENDED TO ENCOURAGE AND CULTIVATE INTEREST IN HUNTINGTON'S DISEASE RESEARCH.TRANSFORMATIVE RESEARCH AWARDS: THESE MILLION-DOLLAR RESEARCH AWARDS, HDF'S LARGEST GRANTS, FUND COLLABORATIVE RESEARCH TEAMS TO CREATE INNOVATIVE WAYS TO STUDY NEW PATHOGENIC DISEASE MECHANISMS AND TREATMENT MODALITIES IN HUNTINGTON'S DISEASE.HD CAREER ADVANCEMENT GRANTS: THESE ARE OUR NEWEST AWARDS WITH GRANTS BEGINNING IN 2025. THIS INCUBATOR PROGRAM SUPPORTS YOUNG INVESTIGATORS BY PROVIDING RESOURCES AND TOOLS TO BUILD THE NECESSARY SKILLS TO BRIDGE THE TRANSITION FROM POSTDOCTORAL POSITION TO TENURE-TRACK PRIMARY INVESTIGATOR. OUR GOAL THROUGH THIS PROGRAM AND OUR POSTDOCTORAL FELLOWSHIPS IS TO ENGAGE AND RETAIN THE BRIGHTEST MINDS IN HD RESEARCH BY FUNDING AND MENTORING EARLY-CAREER SCIENTISTS.HDF-FUNDED RESEARCHERS HAVE MADE SIGNIFICANT STRIDES IN APPLYING ADVANCED TECHNIQUES SUCH AS ARTIFICIAL INTELLIGENCE (AI), CRISPR AND BRAIN MAPPING, LEADING TO TREMENDOUS PROMISE FOR POTENTIAL TREATMENTS FOR HUNTINGTON'S DISEASE.
    Expenses $3,796,690 · grants $3,152,522 · revenue $52,500

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026990 on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
23-7376197
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
1974
Accounting year ends
December
Files
Form 990 or 990-EZ
Assets (IRS master file)
$23,135,759
Income (IRS master file)
$11,041,255

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2025$4,081,669$4,326,391$23,135,759IRS
990December 2024$7,899,221$4,524,145$21,978,294IRS
990December 2023$2,578,841$4,738,635$18,234,308XML
990December 2022$4,522,686$2,603,305$16,776,193IRS
990December 2021$3,846,649$2,967,624$18,145,612XML
990December 2020–––IRS
990December 2018–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 23-7376197).

Questions about HUNTINGTON S DISEASE FOUNDATION

What is the EIN of HUNTINGTON S DISEASE FOUNDATION?
The employer identification number (EIN) of HUNTINGTON S DISEASE FOUNDATION is 23-7376197.
Is HUNTINGTON S DISEASE FOUNDATION tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1974.
Are donations to HUNTINGTON S DISEASE FOUNDATION tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does HUNTINGTON S DISEASE FOUNDATION file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of HUNTINGTON S DISEASE FOUNDATION due?
The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
When did HUNTINGTON S DISEASE FOUNDATION last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2025.
Who is the principal officer of HUNTINGTON S DISEASE FOUNDATION?
The 990 for the year ended December 31, 2025 names MEGHAN DONALDSON.
Who are the officers and directors of HUNTINGTON S DISEASE FOUNDATION?
The 990 for the year ended December 31, 2025 lists 21 people; 5 received compensation from the organization, the highest $155,000 (SARAH HERNANDEZ PHD, DIR. OF RESEARCH PROGRAMS).
How much revenue does HUNTINGTON S DISEASE FOUNDATION have?
On its 990 for the year ended December 31, 2025 it reported revenue of $4,081,669, expenses of $4,326,391 and total assets of $23,135,759 at year end.

Other nonprofits in NEW YORK

All nonprofits in NEW YORK · New York · Medical research